Surgical Management of Clostridium difficile Colitis
- PMID: 24294121
- PMCID: PMC3577611
- DOI: 10.1055/s-0032-1329390
Surgical Management of Clostridium difficile Colitis
Abstract
Clostridium difficile infection (CDI) will progress to fulminant disease in 3 to 5% of cases. With the emergence of hypervirulent, multidrug-resistant strains, the incidence and severity of disease are continuing to rise. Prompt identification, early resuscitation, and treatment are critical in preventing morbidity and mortality in this increasingly common condition. Discontinuation of antibiotics and treatment with oral vancomycin and intravenous or oral metronidazole are first-line treatments, but complicated cases may require surgery. Subtotal colectomy with ileostomy remains the standard of care when toxic megacolon, perforation, or an acute surgical abdomen is present, but mortality rates are high. Recognition of risk factors for fulminant CDI and earlier surgical intervention may decrease mortality from this highly lethal disease.
Keywords: Clostridium difficile; colectomy; pseudomembranous colitis.
Figures
References
-
- Bartlett J G, Chang T W, Gurwith M, Gorbach S L, Onderdonk A B. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med. 1978;298(10):531–534. - PubMed
-
- Bartlett J G, Moon N, Chang T W, Taylor N, Onderdonk A B. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology. 1978;75(5):778–782. - PubMed
-
- Butler M, Bliss D, Drekonja D, Rockville, MD: U.S. Department of Health and Human Services, Agency for Healthcare Research and Quality; 2011. Effectiveness of early diagnosis, prevention, and treatment of Clostridium difficile infection. - PubMed
-
- Sailhamer E A Carson K Chang Y et al. Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality Arch Surg 20091445433–439., discussion 439–440 - PubMed
